Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BANNER CORPBANR · Entity 4398 | Director | November 18, 2016 | November 22, 2016 |
| CLOROX CO /DE/CLX · Entity 3474 | Director | December 31, 2025 | January 05, 2026 |
| LEVI STRAUSS & COLEVI · Entity 3651 | Director | August 08, 2025 | August 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BANNER CORP
Report date November 18, 2016 · Filed November 22, 2016
Jointly reported with FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP, FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP, FFL Individual Partners III, L.P., FFL EXECUTIVE PARTNERS III LP, Friedman Fleischer & Lowe GP III, L.P., Friedman Fleischer & Lowe GP III, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 571,800 |
Reported balance
After 2016-11-18 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2016-11-18 · Sale · Disposed 422,693 · Balance 571,800 F2: Held directly by Friedman Fleischer & Lowe Capital Partners III, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 378,924 |
Reported balance
After 2016-11-18 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2016-11-18 · Sale · Disposed 280,111 · Balance 378,924 F3: Held directly by Friedman Fleischer & Lowe Parallel Fund III, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 12,113 |
Reported balance
After 2016-11-18 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2016-11-18 · Sale · Disposed 8,954 · Balance 12,113 F4: Held directly by FFL Individual Partners III, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 11,151 |
Reported balance
After 2016-11-18 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2016-11-18 · Sale · Disposed 8,242 · Balance 11,151 F5: Held directly by FFL Executive Partners, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 697 |
Reported balance
Holding disclosure · report date 2016-11-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 697 F1: Represents award of restricted stock pursuant to 2014 Omnibus Incentive Plan; shares fully vest on April 25, 2017. These shares are subject to forfeiture and to limits on transferability until they vest. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents award of restricted stock pursuant to 2014 Omnibus Incentive Plan; shares fully vest on April 25, 2017. These shares are subject to forfeiture and to limits on transferability until they vest.
F2: Held directly by Friedman Fleischer & Lowe Capital Partners III, L.P.
F3: Held directly by Friedman Fleischer & Lowe Parallel Fund III, L.P.
F4: Held directly by FFL Individual Partners III, L.P.
F5: Held directly by FFL Executive Partners, L.P.
F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1.
F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer.
CLOROX CO /DE/
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,018.8638 |
Reported balance
After 2025-11-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-06 · Grant · Acquired 219.3396 · Balance 19,018.8638 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,238.021 |
Reported balance
After 2025-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-31 · Grant · Acquired 1,219.1572 · Balance 20,238.021 F1: 1-for-1 F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,383.2827 |
Reported balance
After 2025-12-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-12-31 · Grant · Acquired 145.2617 · Balance 20,383.2827 F1: 1-for-1 F5: Receipt of Deferred Stock Units in lieu of portion of quarterly director's fees. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F5: Receipt of Deferred Stock Units in lieu of portion of quarterly director's fees.
LEVI STRAUSS & CO
Report date August 08, 2025 · Filed August 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 64,500 |
Reported balance
After 2025-08-08 transaction · row 1
1 source rowRow 1 · 2025-08-08 · Grant · Acquired 213 · Balance 64,500 F1: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs. |
| Class B Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 116,515 |
Reported balance
After 2025-08-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-08-08 · Grant · Acquired 187 · Balance 116,515 F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs.
F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F3: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 20, 2019 Filed Aug 9, 2019 20:12 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 7,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045328 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,657 F1 · shares: The shares are represented by restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. Read SEC document |
| May 10, 2019 Filed Jul 2, 2019 21:49 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 43.6078 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-009917 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,775.1054 Underlying: Common Stock · 43.6078 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 23:50 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 186.9625 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-006210 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,731.4976 Underlying: Common Stock · 186.9625 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 25, 2019 Filed Mar 28, 2019 00:17 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | OtherClass B Common Stock · Derivative | 19,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021535 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,600 Underlying: Class A Common Stock · 19,600 shares Expires not disclosed F1 · security: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F4 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F4 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F4 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F4 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| March 25, 2019 Filed Mar 28, 2019 00:17 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | OtherClass A Common Stock | 92,540 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021535 · doc4.xml · nonDerivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,540 F1 · shares: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F3 · shares: Each share is represented by an RSU), 6,950 of which are issuable in respect of dividend equivalent rights on the RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The RSUs vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Read SEC document |
| March 25, 2019 Filed Mar 28, 2019 00:17 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | OtherCommon Stock | 112,140 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021535 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F1 · shares: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F2 · shares: 92,540 of the shares are represented by restricted stock units (RSUs), 6,950 of which are issuable in respect of dividend equivalent rights on the RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in a series of three (3) equal installments on the dates that are thirteen (13), twenty-four (24) and thirty-six (36) months following the date of grant. F1 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Read SEC document |
| March 25, 2019 Filed Apr 21, 2023 22:23 UTC Amendment | LEVI STRAUSS & CO LEVI · Entity 3651 | OtherClass B Common Stock · Derivative | 92,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025244 · doc4a.xml · derivative · entry 4 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,140 Underlying: Class A Common Stock · 92,540 shares Expires not disclosed F2 · security: This Form 4/A is being filed to correct the disclosure relating to such RSUs (the "Class B RSUs") set forth in the Form 4 filed on March 27, 2019 (the "Original Form 4"), which were inadvertently disclosed in Table I instead of Table II in the Original Form 4. DERs issued with regard to the Class B RSUs after the date of the Original Form 4 were also incorrectly reported on Table I instead of Table II, as a result of the initial misclassification. F3 · security: Each share is represented by a restricted stock unit (RSU) that may be settled in shares of Class B Common Stock, including RSUs previously issued in the form of dividend equivalent rights (DERs). Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. The RSUs vest in a series of three equal installments on the dates that are 13, 24 and 36 months following the date of grant. Certain of such RSUs are subject to a deferral delivery feature. F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| March 25, 2019 Filed Apr 21, 2023 22:23 UTC Amendment | LEVI STRAUSS & CO LEVI · Entity 3651 | OtherClass B Common Stock · Derivative | 19,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025244 · doc4a.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,600 Underlying: Class A Common Stock · 19,600 shares Expires not disclosed F1 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| March 25, 2019 Filed Apr 21, 2023 22:23 UTC Amendment | LEVI STRAUSS & CO LEVI · Entity 3651 | OtherCommon Stock | 92,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025244 · doc4a.xml · nonDerivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Immediately prior to the closing of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · security: This Form 4/A is being filed to correct the disclosure relating to such RSUs (the "Class B RSUs") set forth in the Form 4 filed on March 27, 2019 (the "Original Form 4"), which were inadvertently disclosed in Table I instead of Table II in the Original Form 4. DERs issued with regard to the Class B RSUs after the date of the Original Form 4 were also incorrectly reported on Table I instead of Table II, as a result of the initial misclassification. F3 · shares: Each share is represented by a restricted stock unit (RSU) that may be settled in shares of Class B Common Stock, including RSUs previously issued in the form of dividend equivalent rights (DERs). Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. The RSUs vest in a series of three equal installments on the dates that are 13, 24 and 36 months following the date of grant. Certain of such RSUs are subject to a deferral delivery feature. Read SEC document |
| March 25, 2019 Filed Apr 21, 2023 22:23 UTC Amendment | LEVI STRAUSS & CO LEVI · Entity 3651 | OtherCommon Stock | 19,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025244 · doc4a.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,540 F1 · security: Immediately prior to the closing of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| February 08, 2019 Filed Apr 2, 2019 23:50 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 40.1146 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-006210 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,544.5351 Underlying: Common Stock · 40.1146 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 179.1144 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000375 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,504.4205 Underlying: Common Stock · 179.1144 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 963.0341 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000375 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,325.3061 Underlying: Common Stock · 963.0341 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 16, 2018 Filed Jan 3, 2019 21:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 31.5854 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000375 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,362.2719 Underlying: Common Stock · 31.5854 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 21:50 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 166.2124 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-014172 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,330.6865 Underlying: Common Stock · 166.2124 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 17, 2018 Filed Oct 2, 2018 21:50 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 33.3887 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-014172 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,164.4741 Underlying: Common Stock · 33.3887 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 184.8429 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-011335 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,131.0854 Underlying: Common Stock · 184.8429 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 11, 2018 Filed Jul 3, 2018 20:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 39.0814 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-011335 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,946.2425 Underlying: Common Stock · 39.0814 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 23:57 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 187.8146 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-006973 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,907.1611 Underlying: Common Stock · 187.8146 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 09, 2018 Filed Apr 2, 2018 23:57 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 30.5789 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-006973 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,719.3465 Underlying: Common Stock · 30.5789 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 168.0785 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000437 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,688.7676 Underlying: Common Stock · 168.0785 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,002.0689 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000437 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,520.6891 Underlying: Common Stock · 1,002.0689 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 13, 2017 Filed Jan 3, 2018 23:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 21.7454 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000437 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,518.6202 Underlying: Common Stock · 21.7454 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 20:27 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 189.5232 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-015772 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,496.8748 Underlying: Common Stock · 189.5232 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 04, 2017 Filed Oct 3, 2017 20:27 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 20.5289 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-015772 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,307.3516 Underlying: Common Stock · 20.5289 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 22:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 187.6313 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-012224 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,286.8227 Underlying: Common Stock · 187.6313 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 21:56 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 187.6313 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-012285 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,286.8227 Underlying: Common Stock · 187.6313 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 05, 2017 Filed Jul 5, 2017 22:07 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 18.5455 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-012224 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,099.1913 Underlying: Common Stock · 18.5455 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 05, 2017 Filed Jul 5, 2017 21:56 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 18.5455 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-012285 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,099.1913 Underlying: Common Stock · 18.5455 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 21:37 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 185.4187 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-007480 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,080.6458 Underlying: Common Stock · 185.4187 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 10, 2017 Filed Apr 4, 2017 21:37 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 18.1192 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-007480 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,895.2271 Underlying: Common Stock · 18.1192 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 208.2986 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000365 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,877.1079 Underlying: Common Stock · 208.2986 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,136.5522 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000365 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,668.8093 Underlying: Common Stock · 1,136.5522 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 00:05 UTC | BANNER CORP BANR · Entity 4398 | SaleCommon stock, $0.01 par value per share | 8,242 | $48.32 | $398,253.44 |
DisclosureSEC source: 0001140361-16-087474 · doc1.xml · nonDerivative · entry 5 Fleischer Spencer C · CIK 0001235824 · Director FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP · CIK 0001412166 · Director FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP · CIK 0001412164 · Director FFL Individual Partners III, L.P. · CIK 0001616049 · Director FFL EXECUTIVE PARTNERS III LP · CIK 0001447193 · Director Friedman Fleischer & Lowe GP III, L.P. · CIK 0001616050 · Director Friedman Fleischer & Lowe GP III, LLC · CIK 0001615971 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 11,151 F5 · ownership.nature: Held directly by FFL Executive Partners, L.P. F6 · ownership.nature: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7 · ownership.nature: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 00:05 UTC | BANNER CORP BANR · Entity 4398 | SaleCommon stock, $0.01 par value per share | 8,954 | $48.32 | $432,657.28 |
DisclosureSEC source: 0001140361-16-087474 · doc1.xml · nonDerivative · entry 4 Fleischer Spencer C · CIK 0001235824 · Director FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP · CIK 0001412166 · Director FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP · CIK 0001412164 · Director FFL Individual Partners III, L.P. · CIK 0001616049 · Director FFL EXECUTIVE PARTNERS III LP · CIK 0001447193 · Director Friedman Fleischer & Lowe GP III, L.P. · CIK 0001616050 · Director Friedman Fleischer & Lowe GP III, LLC · CIK 0001615971 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 12,113 F4 · ownership.nature: Held directly by FFL Individual Partners III, L.P. F6 · ownership.nature: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7 · ownership.nature: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 00:05 UTC | BANNER CORP BANR · Entity 4398 | SaleCommon stock, $0.01 par value per share | 280,111 | $48.32 | $13,534,963.52 |
DisclosureSEC source: 0001140361-16-087474 · doc1.xml · nonDerivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP · CIK 0001412166 · Director FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP · CIK 0001412164 · Director FFL Individual Partners III, L.P. · CIK 0001616049 · Director FFL EXECUTIVE PARTNERS III LP · CIK 0001447193 · Director Friedman Fleischer & Lowe GP III, L.P. · CIK 0001616050 · Director Friedman Fleischer & Lowe GP III, LLC · CIK 0001615971 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 378,924 F3 · ownership.nature: Held directly by Friedman Fleischer & Lowe Parallel Fund III, L.P. F6 · ownership.nature: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7 · ownership.nature: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 00:05 UTC | BANNER CORP BANR · Entity 4398 | SaleCommon Stock, $0.01 par value per share | 422,693 | $48.32 | $20,424,525.76 |
DisclosureSEC source: 0001140361-16-087474 · doc1.xml · nonDerivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP · CIK 0001412166 · Director FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP · CIK 0001412164 · Director FFL Individual Partners III, L.P. · CIK 0001616049 · Director FFL EXECUTIVE PARTNERS III LP · CIK 0001447193 · Director Friedman Fleischer & Lowe GP III, L.P. · CIK 0001616050 · Director Friedman Fleischer & Lowe GP III, LLC · CIK 0001615971 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 571,800 F2 · ownership.nature: Held directly by Friedman Fleischer & Lowe Capital Partners III, L.P. F6 · ownership.nature: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7 · ownership.nature: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. Read SEC document |
| November 14, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 10.7583 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000365 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,532.257 Underlying: Common Stock · 10.7583 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 22:09 UTC | BANNER CORP BANR · Entity 4398 | SaleCommon stock, $0.01 par value per share | 10,360 | $43.24 | $447,966.40 |
DisclosureSEC source: 0001140361-16-085188 · doc1.xml · nonDerivative · entry 5 Fleischer Spencer C · CIK 0001235824 · Director FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP · CIK 0001412166 · Director FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP · CIK 0001412164 · Director FFL Individual Partners III, L.P. · CIK 0001616049 · Director FFL EXECUTIVE PARTNERS III LP · CIK 0001447193 · Director Friedman Fleischer & Lowe GP III, L.P. · CIK 0001616050 · Director Friedman Fleischer & Lowe GP III, LLC · CIK 0001615971 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 19,393 F5 · ownership.nature: Held directly by FFL Executive Partners, L.P. F6 · ownership.nature: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7 · ownership.nature: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 22:09 UTC | BANNER CORP BANR · Entity 4398 | SaleCommon stock, $0.01 par value per share | 11,255 | $43.24 | $486,666.20 |
DisclosureSEC source: 0001140361-16-085188 · doc1.xml · nonDerivative · entry 4 Fleischer Spencer C · CIK 0001235824 · Director FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP · CIK 0001412166 · Director FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP · CIK 0001412164 · Director FFL Individual Partners III, L.P. · CIK 0001616049 · Director FFL EXECUTIVE PARTNERS III LP · CIK 0001447193 · Director Friedman Fleischer & Lowe GP III, L.P. · CIK 0001616050 · Director Friedman Fleischer & Lowe GP III, LLC · CIK 0001615971 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 21,067 F4 · ownership.nature: Held directly by FFL Individual Partners III, L.P. F6 · ownership.nature: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7 · ownership.nature: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 22:09 UTC | BANNER CORP BANR · Entity 4398 | SaleCommon stock, $0.01 par value per share | 352,084 | $43.24 | $15,224,112.16 |
DisclosureSEC source: 0001140361-16-085188 · doc1.xml · nonDerivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP · CIK 0001412166 · Director FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP · CIK 0001412164 · Director FFL Individual Partners III, L.P. · CIK 0001616049 · Director FFL EXECUTIVE PARTNERS III LP · CIK 0001447193 · Director Friedman Fleischer & Lowe GP III, L.P. · CIK 0001616050 · Director Friedman Fleischer & Lowe GP III, LLC · CIK 0001615971 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 659,035 F3 · ownership.nature: Held directly by Friedman Fleischer & Lowe Parallel Fund III, L.P. F6 · ownership.nature: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7 · ownership.nature: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 22:09 UTC | BANNER CORP BANR · Entity 4398 | SaleCommon Stock, $0.01 par value per share | 531,301 | $43.24 | $22,973,455.24 |
DisclosureSEC source: 0001140361-16-085188 · doc1.xml · nonDerivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP · CIK 0001412166 · Director FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP · CIK 0001412164 · Director FFL Individual Partners III, L.P. · CIK 0001616049 · Director FFL EXECUTIVE PARTNERS III LP · CIK 0001447193 · Director Friedman Fleischer & Lowe GP III, L.P. · CIK 0001616050 · Director Friedman Fleischer & Lowe GP III, LLC · CIK 0001615971 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 994,493 F2 · ownership.nature: Held directly by Friedman Fleischer & Lowe Capital Partners III, L.P. F6 · ownership.nature: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7 · ownership.nature: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 21:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 199.7124 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040110 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521.4987 Underlying: Common Stock · 199.7124 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 12, 2016 Filed Oct 4, 2016 21:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 7.8783 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040110 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,321.7863 Underlying: Common Stock · 7.8783 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.